Literature DB >> 30396876

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus

Zeynep Yürük Yıldırım1, Alev Yılmaz1, Cemile Pehlivanoğlu1, Asuman Gedikbaşı2, Mehmet Yıldız3, Ahmet Dirican4, Rüveyde Bundak5, Feyza Darendeliler5, Sevinç Emre1, Ahmet Nayır1.   

Abstract

Objective: Histopathological changes in the kidney in type 1 diabetes mellitus (T1DM) begin before detection of microalbuminuria. Therefore, there is interest in finding a better biomarker for the early detection of diabetic kidney injury. The aim of this present study was to determine whether urinary indicators of fibrosis are detectable early in the development of T1DM in children and if they may predict progressive renal injury.
Methods: Urinary matrix metalloproteinase 2 and 9 (MMP2 and MMP9), tissue inhibitor of metalloproteinase 1 and 2 (TIMP1 and TIMP2) and transforming growth factor-β1 (TGF-β1) were assessed in 33 patients with T1DM with normal renal functions and in 24 healthy controls. Microalbuminuria was not present in the patient group with the exception of three patients. The results were adjusted to urine creatinine (Cr) and the differences between patients and controls were evaluated. These measurements were repeated after one year and the results were compared with the first year results.
Results: Urine MMP2/Cr, MMP9/Cr, TIMP1/Cr, TIMP2/Cr, TGF-β1/Cr were not different between the patient and control groups (p>0.05). There were also no significant differences between the first and second year results for these biomarkers (p>0.05). None of these parameters were correlated with hemoglobin A1c, body mass index and duration of T1DM. Interestingly, all parameters were negatively correlated to age of onset of T1DM (p<0.05).
Conclusion: Our findings suggest that urinary biomarkers of fibrosis do not show an increase in diabetic children without microalbuminuria. The results also indicate that the risk of early fibrosis may increase as age of onset of T1DM decreases.

Entities:  

Keywords:  Type 1 diabetes mellitus; diabetic nephropathy; children; biomarker; MMP; TIMP

Mesh:

Substances:

Year:  2018        PMID: 30396876      PMCID: PMC6571536          DOI: 10.4274/jcrpe.galenos.2018.2018.0221

Source DB:  PubMed          Journal:  J Clin Res Pediatr Endocrinol


  3 in total

1.  Up-regulation of MMP-2 by histone H3K9 β-hydroxybutyrylation to antagonize glomerulosclerosis in diabetic rat.

Authors:  Weigang Luo; Yijin Yu; Hao Wang; Kun Liu; Yu Wang; Minling Huang; Chenhao Xuan; Yanning Li; Jinsheng Qi
Journal:  Acta Diabetol       Date:  2020-08-09       Impact factor: 4.280

2.  Matrix metalloproteinase -2, -9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension.

Authors:  Stella Stabouli; Vasilios Kotsis; Olga Maliachova; Nikoleta Printza; Athanasia Chainoglou; Athanasios Christoforidis; Anna Taparkou; John Dotis; Evangelia Farmaki; Dimitrios Zafeiriou
Journal:  Int J Cardiol Hypertens       Date:  2020-02-06

Review 3.  Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Linh D Do; Brianne G Hritz
Journal:  Cells       Date:  2020-05-25       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.